MedTech EU Regulatory Updates

Stay Informed with the Latest MedTech Regulatory Updates

Medical Devices service image.png

Regulatory Insights for the MedTech Industry

In the fast-evolving Medical Device and MedTech sector, staying ahead of regulatory changes is crucial. Our dedicated page offers a comprehensive overview of the latest guidance, regulations, and updates to help your business stay compliant and informed. From the most recent MDCG guidance to amendments in EU regulations, we ensure you’re equipped with the knowledge needed to navigate the complex regulatory landscape.

Explore the latest updates, including revisions in IVDR and MDR, Q&A releases, and critical changes in clinical evaluations and conformity assessments, all designed to support your regulatory journey.

Contact Us

Regulatory Updates

May 2025:

April 2025:

March 2025:

February 2025:

  • The Spanish Agency of Medicines and Medical Devices (AEMPS, Agencia Española de Productos Sanitarios) launches its profile on Instagram to bring its work closer to citizens. AEMPS profiles in other social networks: X, aimed at all types of audiences; LinkedIn, aimed at the professional field; and YouTube, focused on audiovisual content.
  • Updated MDCG guidance: MDCG 2019-6 rev.5 – Questions and Answers – Requirements Relating to Notified Bodies.
  • European Commission call for applications for pilot coordinated assessment for Clinical Investigations (CI) and Performance Studies (PS) ross multiple Member States as per Articles 78 of the Regulation (EU) 2017/745 (MDR) and 74 of the Regulation (EU) 2017/746 (IVDR) respectively.
  • New European Commission Guidelines: C(2025) 884 – Guidelines on prohibited artificial intelligence practices established by Regulation (EU) 2024/1689 (AI Act).
  • New European Commission Guidelines: C(2025) 924 – Guidelines on the definition of an artificial intelligence system established by Regulation (EU) 2024/1689 (AI Act)
  •  

January 2025:

  • Updated MDCG guidance: MDCG 2023-3 rev.2 – Questions and Answers on vigilance terms and concepts as outlined in the Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746.
  • Updated MDCG guidance: MDCG 2024-7 rev.1 – Preliminary assessment review template – MDR (Regulation (EU) 2017/745) & MDCG 2021-15/MDCG 2024-7 Annex – Annex to Application Form & PAR Template MDR (List of documents).
  • Updated MDCG guidance: MDCG 2024-8 rev.1 – Preliminary assessment review template – IVDR (Regulation (EU) 2017/746) & MDCG 2021-16/MDCG 2024-8 Annex – Annex to Application Form & PAR Template IVDR (List of documents).
  • Updated Contact Points of National Authorities for MDR & IVDR:
  • New MedTech Europe Public Report: MedTech Europe IVDR & MDR Survey Results 2024.
  • Updated MDCG guidance: MDCG 2021-12 rev.1 – FAQon the European Medical Device Nomenclature (EMDN).
  • New MDCG guidance: MDCG 2025-2 – Summary of EMDN 2024 Submissions and outcome of annual revisión.
  • New MDCG guidance: MDCG 2025-3 – Summary of EMDN 2024 Submissions and outcome of annual revision.
  • New MedTech Europe Public Report: MedTech Europe IVDR & MDR Survey Results 2024
  • New Scientific Advice from the Medical Device Expert Panels of the European Medicines Agency: EMA/EX/0000221902/2024 – Advice on SARS-CoV-2 on request from the Medical Device Coordination Group.

2024 Regulatory Updates

December 2024
  • Updated MDCG guidance: MDCG 2022-3 rev.1 – Verification of manufactured class D IVDs by notified bodies.
  • New Team NB position paper – MDR Certification Process (including Pre-application, Application and Post Application phases) – Consensus document.
  • Updated MDCG guidance: MDCG 2019-13 rev.1 – Guidance on sampling of devices for the assessment of the technical documentation.
  • EU rules on medical devices and in vitro diagnostics – Call for evidence for a targeted evaluation by the European Comission.
  • Updated Q&A from the European Comission – The information obligation in case of interruption or discontinuation of supply of certain medical devices and in vitro diagnostic medical devices.
  • REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL on the operation of Article 17 of Regulation (EU) 2017/745 of the European Parliament and of the Council on single-use devices and their reprocessing.
  • Team-NB High level position on the regulatory framework for the medical devices sector.
  • New MedTech Eruope position paper: Smooth transition to the mandatory use of EUDAMED Perspectives from manufacturers.
  • New MDCG guidance: MDCG 2024-16 – Manufacturer Information Form on Interruption or Discontinuation of Supply of certain medical devices and certain in vitro diagnostic medical devices
  • New MDCG guidance: MDCG 2024-15 – Guidance on the publication of the clinical investigation reports and their summaries in the absence of EUDAMED.
  • New MDCG Guidance: MDCG 2023-3 Rev. 1 Questions and Answers on vigilance terms and concepts as outlined in the Regulation (EU) 2017/745 and Regulation (EU) 2017/746
  • New MDCG guidance: MDCG 2024-14 – Guidance on the implementation of the Master UDI-DI solution for contact lenses.
  • New Q&A: Gradual roll out of EUDAMED – Q&As on practical aspects related to the implementation of Regulation (EU) 2024/1860 (Gradual roll out of EUDAMED).
  • New Team-NB position paper: Artificial Intelligence In Medical Devices – Questionnaire (Team-NB AI in MDs).
  • New MDCG guidance: MDCG 2024-11 – Guidance on qualification of in vitro diagnostic medical devices.
  • New MDCG guidance: MDCG 2024-12 – Guidance and templates for conformity assessment bodies, notified bodies, designating authorities, and joint assessment teams.
  • Updated MDCG guidance: MDCG 2021-25 rev.1 – Application of MDR requirements to “legacy devices” and to devices placed on the market prior to 26 May 2021 in accordance with Directives 90/385/EEC or 93/42/EEC.
  • 2024/2849(RSP): European Parliament’s resolution on the urgent need to revise the Medical Devices Regulation.
  • New MDCG guidance: MDCG 2024-13 – Regulatory status of ethylene oxide (EtO) intended for the sterilisation of medical devices.
  • Updated MDCG guidance: MDCG 2022-5 rev.1 – Guidance on borderline between medical devices and medicinal products under Regulation (EU) 2017/745 on medical devices.
  • Commission Implementing Decision (EU) 2024/2631 of 8 October 2024 amending Implementing Decision (EU) 2021/1182 as regards the harmonised standard for aseptic processing of health care products (C/2024/6872);
  • Commission Implementing Decision (EU) 2024/2625 of 8 October 2024 amending Implementing Decision (EU) 2021/1195 as regards harmonised standards for aseptic processing of health care products and clinical performance studies using specimens from human subjects (C/2024/6874);
  • Updated MDCG guidance: MDCG 2021-4 Rev.1 – Guidance on Application of transitional provisions for certification of class D in vitro diagnostic medical devices according to Regulation (EU) 2017/746 (Update of previous guidance).
  • Updated MDCG guidance: MDCG 2020-16 Rev.3– Guidance on Classification Rules for in vitro Diagnostic Medical Devices under Regulation (EU) 2017/746.
  • Updated MDCG guidance: MDCG 2021-5 Rev. 1– Guidance on standardisation for medical devices.
  • New Q&A: Q&A on practical aspects related to the implementation of the extended transitional period provided for in the IVDR, as amended by Regulation (EU) 2024/1860.
  • Updated Q&A: Q&A Rev. 2 on practical aspects related to the implementation of Regulation (EU) 2023/607 – Extension of the MDR transitional period and removal of the “sell off” periods.
  • Publication in the Official Journal of the European Comission of Regulation (EU) 2024/1860 of the European Parliament and of the Council of 13 June 2024 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the obligation to inform in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices.
  • New MDCG guidance: MDCG 2024-10 – Clinical evaluation of orphan medical devices.
  • Updated MDCG guidance: MDCG 2022-13 Rev.1 – Designation, re-assessment and notification of conformity assessment bodies and notified bodies.
  • Updated SCHEER guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices
    covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties

 

  • New MDCG guidance: MDCG 2024-6 – Preliminary re-assessment review (PRAR) form template (MDR)
  • New MDCG guidance: MDCG 2024-7 – Preliminary assessment review (PAR) form template (MDR) 
  • New MDCG guidance: MDCG 2024-8 – Preliminary assessment review (PAR) form template (IVDR)
  • New MDCG guidance: MDCG 2024-9 – Preliminary re-assessment review (PRAR) form template (IVDR)
  • Updated MDCG guidance: MDCG 2022-4 rev.2 – Guidance on appropriate surveillance regarding the transitional provisions under Article 120 of the MDR with regard to devices covered by certificates according to the MDD or the AIMDD
  • New MDCG guidance: MDCG 2024-4– Safety reporting in performance studies of in vitro diagnostic medical devices under Regulation (EU) 2017/746.
  • New MDCG guidance: MDCG 2024-5 – Guidance on the Investigator’s Brochure content.
  • Updated MDCG guidance: MDCG 2022-9 Rev.1– Summary of safety and performance template.

 

  • New MDCG guidance: MDCG 2024-3 – Guidance on content of the Clinical Investigation Plan for clinical investigations of medical devices.
  • New MDCG guidance: MDCG 2024-2 – Procedures for the updates of the EMDN.
  • Commission proposal to extend the transition periods for certain IVDs, the gradual roll-out of Eudamed and an information obligation in case of interruption of supply.
  • Publication on MDR/IVDR Language requirements – Overview of language requirements for manufacturers of medical devices for the information and instructions that accompany a device in a specific country.
  • New MDCG guidance: MDCG 2024-1 – Device Specific Vigilance Guidance (DSVG) Template.

Related Resources

Pharma equipment qualification hero image Case Study

Pharmaceutical Equipment Requalification Case Study

See how Rephine helped a global pharma company streamline equipment requalification across complex sites with a scalable, risk-based approach aligned with Annex 15.
Read More
CPV Header image blog apr 25 Blog

Threat Modelling in Medical Devices: STRIDE for MDR/IVDR Cybersecurity Compliance

Understand how STRIDE and other threat modelling techniques help medical device manufacturers meet MDR/IVDR cybersecurity requirements—plus real-world examples and expert insights.
Read More
Medical Device Guide

Security Risk Management for Medical Devices: MDR & IVDR Compliance Whitepaper

Understand how to embed cybersecurity into the medical device lifecycle with this expert guide from Rephine. Includes MDR/IVDR, FDA, and IMDRF guidance on SRM, threat ...
Read More
Pharma equipment qualification hero image Case Study

Pharmaceutical Equipment Qualification Case Study

See how Rephine helped a global pharmaceutical manufacturer accelerate equipment qualification using a GMP-aligned, risk-based strategy—saving time and improving compliance.
Read More
Pharma equipment qualification hero image Blog

Equipment Qualification in the Pharmaceutical Industry: Lifecycle, Best Practices & Risk-Based Tips

Discover how to streamline equipment qualification in the pharmaceutical industry using a risk-based approach, modular documentation, and smart validation strategies. Learn practical tips to reduce ...
Read More
MedTech hero image blog may 25 Blog

Transitioning from FDA QSR to QMSR: What Medical Device Companies Need to Know

The FDA has finalized a major update to 21 CFR Part 820, transitioning from the long-standing Quality System Regulation (QSR) to the new Quality Management ...
Read More
Medical Software Testing MedTech Guide Header Image (1500 x 844 px) Guide

Medical Device Software Testing for MDR/IVDR Compliance | Rephine Guide

Learn when medical software qualifies as a medical device under EU MDR & IVDR regulations. Explore classification rules, examples, and compliance tips for manufacturers.
Read More
AI Act WP MedTech Header Image (1500 x 844 px) Medical Device

The Artificial Intelligence Act (EU 2024/1689) Whitepaper: Key Obligations, Risks, and Compliance

Learn when medical software qualifies as a medical device under EU MDR & IVDR regulations. Explore classification rules, examples, and compliance tips for manufacturers.
Read More
Medical Software as MD MedTech Guide Header Image (1500 x 844 px) Guide

When Does Medical Software Qualify as a Medical Device? | MDR & IVDR Guide

Learn when medical software qualifies as a medical device under EU MDR & IVDR regulations. Explore classification rules, examples, and compliance tips for manufacturers.
Read More

Let's get in touch

Please get in touch. Our expert GMP audit team is only a click away, on standby to answer all your questions.
Email: [email protected]
Social: Linkedin

REPHINE HQ

REPHINE BARCELONA S.L.U

  • Barcelona, Spain                               
  • +34 934 178065

REPHINE CHINA

  • Shanghai, China 

REPHINE INDIA

  • Hyderabad, India                               

Contact Us